Concentration of Carbamazepine (Tegretol®) in Serum and in Cerebrospinal Fluid in Patients with Epilepsy

This publication has 16 references indexed in Scilit:

• Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants
  The Journal of Pediatrics, 1971
• ABNORMAL PHARMACOKINETICS OF PHENYTOIN IN A PATIENT WITH URÆMIA
  The Lancet, 1970
• Relation of EEG and Seizures to Phenobarbital in Serum
  Archives of Neurology, 1968
• Unterschiede zwischen der Proteinbindung Neugeborener und Erwachsener und ihre Bedeutung für die pharmakologische Wirkung
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1968
• THE METABOLIC CONVERSION OF PRIMIDONE (MYSOLINE®) TO PHENOBARBITONE IN PATIENTS UNDER LONG-TERM TREATMENT
  Acta Neurologica Scandinavica, 1967
• Clinical pharmacology of the new penicillins: II. Effect of drugs which interfere with binding to serum proteins
  Clinical Pharmacology & Therapeutics, 1966
• Report on the Anti‐Epileptic Action of Tegretol
  Epilepsia, 1964
• Studies on the metabolism of diphenylhydantoin (Dilantin)
  Neurology, 1961
• 5,5‐Diphenylhydantoin (Dilantin ®) Blood Levels after Oral or Intravenous Dosage in Man ¹)
  Acta Pharmacologica et Toxicologica, 1960
• Blood Serum and Cerebrospinal Fluid Levels and Renal Clearance of Phenemal*) in Treated Epileptics**).
  Acta Pharmacologica et Toxicologica, 1954